Universities Allied for Essential Medicines

Universities Allied for Essential Medicines
Name	Universities Allied for Essential Medicines
Formation	2001
Type	Student-run non-profit
Region served	Global

Universities Allied for Essential Medicines is a student-led advocacy organization originating in 2001 that campaigns for equitable access to medical technologies and research practices at academic institutions. It engages with policy debates, university licensing, and global health initiatives to promote affordable medicines, vaccines, and diagnostics across contexts such as Pharmaceutical industry, Global health, Global North, Global South, and Intellectual property. The network has chapters at universities and collaborates with actors across World Health Organization, Médecins Sans Frontières, Bill & Melinda Gates Foundation, National Institutes of Health, and other institutions.

History

Founding activists drew inspiration from campaigns at Harvard University, Massachusetts Institute of Technology, Yale University, University of British Columbia, and other campuses, responding to controversies involving Novartis AG, Eli Lilly and Company, GlaxoSmithKline, Pfizer, and Merck & Co.. Early efforts intersected with debates around the Doha Declaration on the TRIPS Agreement and Public Health, Access to Medicines Index, and initiatives like the Global Fund to Fight AIDS, Tuberculosis and Malaria and Doctors Without Borders. The group expanded amid student movements influenced by events such as the 2000s antiglobalization movement, activism at Columbia University, Oxford University, and campaigns linked to the AIDS epidemic in Africa, connecting to researchers from Johns Hopkins University and Imperial College London. Over time it adapted tactics shaped by precedents set in campaigns at University of California, Berkeley, University of Toronto, Stanford University, and McGill University.

Mission and Goals

The stated mission emphasizes equitable access to essential medicines through institutional policy change at universities like University of Oxford, University of Cambridge, Harvard Medical School, Yale School of Medicine, and UCL. Goals include reforming technology transfer offices influenced by practices at Columbia Technology Ventures, promoting licensing models reflecting precedents from Medicines Patent Pool, aligning with standards in Human Rights Council discussions, and advocating for research norms akin to principles in Declaration of Helsinki, Nuremberg Code, and initiatives championed by Paul Farmer and Partners In Health. The organization frames objectives alongside global frameworks such as Sustainable Development Goals and bodies including UNICEF and World Trade Organization.

Campaigns and Activities

Campaigns have targeted university licensing with actions referencing agreements involving Gilead Sciences, Bayer AG, and AstraZeneca, and have campaigned for open access to work by researchers like those at Karolinska Institutet and Weill Cornell Medicine. Activities include student organizing, policy briefings for institutions such as European Commission, submissions to panels like WHO Expert Committee on Selection and Use of Essential Medicines, and collaborations with advocacy groups such as Oxfam, Public Citizen, Health Action International, and Treatment Action Campaign. Tactical examples include petitions circulated at University of Pennsylvania, teach-ins modeled after events at Brown University, and negotiations mirroring agreements brokered by Unitaid. They have promoted open science initiatives akin to efforts by Creative Commons, Open Access Scholarly Publishers Association, and SPARC (the Scholarly Publishing and Academic Resources Coalition).

Organizational Structure and Chapters

The network operates through student-run chapters at institutions including University of Michigan, University of California, San Francisco, University of Sydney, National University of Singapore, Universidad Nacional Autónoma de México, Pontifical Catholic University of Chile, and University of Cape Town. Governance has included steering committees, regional coordinators, and collaboration with alumni and researchers from institutions like London School of Hygiene & Tropical Medicine, Karolinska Institutet, and Keio University. Chapters often liaise with campus offices such as Technology Transfer Office analogues and legal clinics modeled after programs at Stanford Law School and University of Chicago Law School to draft institutional policy proposals and negotiate model licensing terms influenced by precedent agreements at University of British Columbia and University of Pennsylvania Perelman School of Medicine.

Impact and Criticism

Supporters cite outcomes such as revised licensing policies at universities comparable to changes at Emory University and adoption of global access provisions inspired by the MPP (Medicines Patent Pool), while critics argue the group’s strategies can conflict with revenue objectives pursued by offices like Yale University’s Office of Cooperative Research and corporate partners including Johnson & Johnson. Debates reference cases involving patent pooling, compulsory licensing disputes, and tensions similar to controversies around Bayh–Dole Act-era technology transfer in the United States Congress and scrutiny by bodies like European Court of Justice. Scholarly critiques from academics at Harvard Kennedy School, SOAS University of London, and Columbia Law School have examined trade-offs between access advocacy and incentives for biomedical innovation championed by firms such as Roche and Sanofi.

Funding and Partnerships

Funding sources and partnerships have included collaborations with NGOs like Medicines Sans Frontiers affiliates, grants from philanthropic entities including Wellcome Trust, programmatic ties to Unitaid, and in-kind support from university departments at Yale, Harvard, University of Toronto, and University of Oxford. The organization has navigated relationships with research funders including Bill & Melinda Gates Foundation, Canadian Institutes of Health Research, and European Research Council, while maintaining networks with policy actors such as World Health Organization, United Nations Development Programme, and advocacy coalitions like People’s Health Movement. Fiscal transparency and partnership choices have periodically prompted discussion with university administrators and external stakeholders at forums like World Health Assembly and Global Health Council.

Category:Global health organizations